Graduate
Martin Carroll has been elected to the board of directors of Inotek Pharmaceuticals, a biopharmaceutical company headquartered in Lexington, Mass. He also has been elected board chair. Previously, he led global strategy and development for Boehringer Ingelheim. He also is a board member of Catalent, TherapeuticsMD, and Mallinckrodt Pharmaceuticals.